May 20, 2016/Neurosciences/Research

Laser Spine Surgery: Panacea, Placebo or Something in Between?

Guidance for counseling patients amid the flurry of marketing

LASER-SPINAL-SUGERY

By Ryan Brennan, MD, and Thomas E. Mroz, MD

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

In recent years, patients have been inundated by advertising and social media campaigns that make laser spine surgery sound like a real-life, science fiction-inspired cure-all. As a result, increasing numbers of patients are expressing interest in this alternative to standard surgical treatments of spinal conditions. The heavy marketing push that positions this surgical technique as a panacea has some spine surgeons tamping down the claims.

What patients — and even some physicians and surgeons — might not know is that this technique has been utilized for nearly 30 years and is an effective approach in selected patients.

Background and applications

Peter Ascher and Daniel Choy became the pioneers of laser spine therapy in 1986, performing the first percutaneous laser disk decompression (PLDD) procedure at the Neurosurgical Department, University of Graz, in Austria.1

The first and still most common application of laser spine therapy is for the treatment of lumbar herniated nucleus pulposus (HNP).

Today, advances in technology, the development of new lasers and equipment, and improved imaging have allowed for the expansion of laser spine interventions to include the cervical, thoracic and lumbar spine.

Applications include percutaneous laser disk decompression of the cervical, thoracic and lumbar spine; laser-assisted posterior cervical foraminotomies and diskectomy for lateral and foraminal cervical disk herniation; laser-assisted anterior cervical corpectomy for cervical myelopathy patients with multilevel ossification of the posterior longitudinal ligament; and laser ablation of spinal growths such as tumors and vascular lesions.

Patient selection criteria for laser spine surgery is similar to that for conventional open surgery: ages 18 to 70, sciatica or cervical radiculopathy due to lumbar or cervical disk herniation for which conservative measures have failed and disk herniation of less than one-third the diameter of the central canal, without concomitant lateral recess stenosis or sequestration.

The use of laser therapy has spread worldwide.

Advertisement

Differing theories about how PLDD works

Choy has theorized that the use of PLDD centers on the principle that the disk, surrounded by a fibrous annular ring, represents an enclosed hydrologic space and that laser ablation of even a small amount of intradiskal material can lead to a reduction in the intradiskal pressure that is significantly disproportionate to the reduced volume.2,3 As a result, a newly created vacuum within the disk pulls the bulging or herniated disk fragment back into this space, thereby relieving the pressure on the neural elements.2 This theory, however, is not proven — and many doubt that this actually occurs.

Others have suggested that the drop in intradiskal pressure is a placebo byproduct of placing the needle into the disk and not due to the laser ablation itself. However, intradiskal pressure measurements have confirmed that the disk pressure remains stable when the needle is placed and is reduced only after the laser ablation is completed.4

Achieving optimal outcomes

To obtain optimal outcomes using the percutaneous approach to laser therapy, proper placement of the needle tip just interior to the annulus is key, with the needle parallel to the disk space and centered between the endplates of the levels above and below the affected disk. An optical fiber is then introduced into the intervertebral disk, allowing administration of laser thermal energy.3

Advantages of PLDD include outpatient care, shorter hospitalizations and earlier return to work.

Clinical research to date

To date, most clinical studies of this technology are level 2B data (i.e., individual cohort studies, including low-level randomized controlled trials with less than 80 percent follow-up), as defined by the National Institutes of Health’s levels of evidence scale.

In the laser spine therapy literature, successful outcomes are measured primarily through the assessment of post-procedure pain and disability levels using standard measures such as the Visual Analog Scale (VAS), the Oswestry Disability Index (ODI) and the MacNab criteria, which ranks the patient’s pain and any impact on activity from excellent to poor. In the longest follow-up periods to date (17 years), successful outcomes reported in the literature range from 44 to 92 percent (typically 70 to 89 percent) of cases.1 When laser spine surgery is successful, time from surgery to return to work can be one week or less.1

Although rare severe complications have been reported with laser spine surgery, the overall complication rates (0.3 to 1 percent per year) remain lower than those for conventional spine surgery (about 2 percent per year), and these severe complications appear to be aberrations rather than a reflection of the norm.1 The most common complication appears to be diskitis associated with the percutaneous needle placement, though in reported cases this was mild to moderate in severity and treated successfully with IV antibiotic therapy

In a 17-year follow-up report, Choy described how this procedure, due to low production of scar tissue, may also confer advantages in revision surgery over open techniques. He also reported that PLDD was not associated with a single nerve or cord injury. Choy suggested that the sustained results demonstrated in this long term follow-up study clearly rule out the placebo effect that many conventional spine surgeons have asserted occurs in these cases.

Advertisement

Potential socioeconomic impact

With conventional open spine surgery, patients typically return to work after six weeks. With laser therapies such as PLDD, some studies report return to work in as few as five days. The faster return-to-work time and lower reported overall complication rate of this minimally invasive surgical technique in theory carries a significant socioeconomic impact, though this is not yet validated

A literature search did not reveal any prospective, randomized, directly comparative studies to evaluate the socioeconomic impact of conventional open versus laser spine surgery. Further evaluation is needed to determine the true comparative cost-benefit ratio of open versus laser spine surgery.

Looking forward

A review of the literature suggests that when patients are appropriately selected for laser spine procedures, there is a low infection rate, few complications and outcomes comparable to those achieved with conventional surgical options.

Further prospectively conducted randomized controlled trials are needed to validate outcome parameters and rule out potential investigator bias in the early literature. If outcomes are validated, the potential socioeconomic and clinical impact of wider adoption of this technique could be significant.

Dr. Brennan is Chief Spine Fellow, Neurosurgery, in the Center for Spine Health. He can be reached at brennar@ccf.org.

Dr. Mroz is Co-Director of the Center for Spine Health and Director of the Spine Surgery Fellowship Program. He can be reached at mrozt@ccf.org or 216.445.9232.

References (full references available upon request)

  1. Choy DS, Hellinger J, Hellinger S, Tassi GP, Lee SH. 23rd anniversary of Percutaneous Laser Disc Decompression (PLDD). Photomed Laser Surg. 2009;27(4):535-538.
  2. Choy DS. Percutaneous laser disc decompression. J Clin Laser Med Surg. 1995;13(3):125-126.
  3. Goupille P, Mulleman D, Mammou S, Griffoul I, Valat JP. Percutaneous laser disc decompression for the treatment of lumbar disc herniation: A review. Semin Arthritis Rheum. 2007;37(1):20-30.
  4. Choy DS, Altman P. Fall of intradiscal pressure with laser ablation. J Clin Laser Med Surg. 1995;13(3):149-151.

Related Articles

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

22-NEU-2959102-CQD-Hero-650×450
June 15, 2022/Neurosciences/Research
MINDS Study Will Assess Lifestyle Interventions for Slowing Brain Pathology in Preclinical Stages

New grant-funded investigation illustrates impact and reach of Cleveland Clinic Brain Study

22-NEU-2671014-CQD-650×450-Type
March 9, 2022/Neurosciences/Research
A Closer Look at the Cleveland Clinic Brain Study

How the new longitudinal investigation could become the Framingham Heart Study of brain health

20-NEU-1959738 powered-exoskeleton-for-gait-training_650x450
October 23, 2020/Neurosciences/Research
Study Signals Potential of Powered Exoskeleton for Gait Training in Multiple Sclerosis

Pilot findings show good patient acceptance and safety, early hints of efficacy

20-NEU-1990660-sleep-symptoms-in-health-workers-650×450
October 21, 2020/Neurosciences/Research
Electronic Screening for Sleep Disorders Among Healthcare Workers Is Feasible – and Sorely Needed

Study finds high prevalence of symptoms, willingness to seek treatment

20-NEU-1946228 neurofilaments_650x450
September 9, 2020/Neurosciences/Research
Serum Neurofilament Light as a Progressive MS Biomarker: Guideposts for the Road Ahead

Panel outlines research priorities around a promising alternative to imaging markers

20-NEU-1951118_Impella-temporary-LVAD_650x450_ (1)
September 4, 2020/Neurosciences/Research
Study Finds Clues to Acute Neurologic Events With Short-Term Impella Cardiac Support

Suspected factors include antithrombotic intensity, time on device, presence of thrombocytopenia

20-NEU-1929179 deep-brain-stimulation-for-TBI_650x450
September 3, 2020/Neurosciences/Research
Could DBS of the Cerebellar Dentate Nucleus Enhance Post-TBI Rehabilitation?

Preclinical studies will assess whether method developed for stroke recovery curbs deficits after brain injury

Ad